On March 19, 2021, HCA Healthcare, Inc. filed a definitive proxy statement soliciting proxies and urged the shareholders to vote against a shareholder proposal, requesting the Compensation Committee of the board of directors publish a report analyzing the feasibility of increasing the impact of the Company’s performance on quality metrics on the senior executive compensation arrangements described in the Company’s annual proxy materials, submitted by Kurt Freeman at the Company’s 2021 annual meeting of shareholders scheduled to be held on April 28, 2021.